Evidence map›Paper›PMID 30474548›Full record

ArticleLipids in health and disease2018

Risk factors of hepatic function alterations in hospitalized adult patients treated with short-term parenteral nutrition receiving the same lipid composition at the same dose.

Josep Llop-Talaveron, Maria B Badia-Tahull, Toni Lozano-Andreu, Ana Suarez-Lledo, Elisabet Leiva-Badosa

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Josep Llop-TalaveronPharmacy Department, Hospital Universitari Bellvitge, IDIBELL, Universitat Barcelona, c/Feixa Llarga s/n 08917 L'Hospitalet de Llobregat, Barcelona, Spain.
Maria B Badia-TahullPharmacy Department, Hospital Universitari Bellvitge, IDIBELL, Universitat Barcelona, c/Feixa Llarga s/n 08917 L'Hospitalet de Llobregat, Barcelona, Spain. mbadia@bellvitgehospital.cat.
Toni Lozano-AndreuPharmacy Department, Hospital Universitari Bellvitge, IDIBELL, Universitat Barcelona, c/Feixa Llarga s/n 08917 L'Hospitalet de Llobregat, Barcelona, Spain.
Ana Suarez-LledoPharmacy Department, Hospital Universitari Bellvitge, IDIBELL, Universitat Barcelona, c/Feixa Llarga s/n 08917 L'Hospitalet de Llobregat, Barcelona, Spain.
Elisabet Leiva-BadosaPharmacy Department, Hospital Universitari Bellvitge, IDIBELL, Universitat Barcelona, c/Feixa Llarga s/n 08917 L'Hospitalet de Llobregat, Barcelona, Spain.
Institut d'Investigació Biomédica de Bellvitge · ESBellvitge University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh doses and vegetable origin of lipid emulsions (LE) are prominent factors for liver test (LT) alterations in patients treated with parenteral nutrition (PN). This study aims to determine incidence of LT alterations, and risk factors related to these alterations in patients with short term PN with homogenous LE.

methodsAdult non-critically ill hospitalized patients, with normal LTs at the beginning of PN, receiving 0.8 g/kg/day of an olive/soybean LE were included. A paired Student t-test was applied to compare final with initial LT values. LT variation (end vs start of PN) according to type of surgery and infection was studied by means of an analysis of the variance. Univariate and multivariate analyses were constructed to relate the variations of each of the 4 LTs with the adjustment variables.

resultsOne hundred eighty one patients (66.57 ± 12.89 years; 72.4% men), 66.8% suffered from cancer. Final LT values increased from initial values for gamma-glutamyltransferase (GGT) 2.69 ± 2.49 μkat/L vs 0.55 ± 0.36 μkat/L, alkaline phosphatase (AP) 1.97 ± 1.49 μkat/L vs 1.04 ± 0.33 μkat/L, and alanine aminotransferase (ALT) 0.57 ± 0.92 μkat/L vs 0.32 ± 0.26 μkat/L. GGT and AP variations were associated with days of PN; GGT, AP and total bilirubin with surgical patients, AP variations with infection, and GGT with cancer. Multivariate analysis: elevation of GGT, AP and ALT was related to infection, days of PN and surgery.

conclusionsFactors that increased the risk of LTs elevation during short term PN treatment were duration of PN, surgery, cancer, and infection associated with oxidative stress.

Indexed as

Alanine Transaminasegamma-GlutamyltransferaseHospitalizationHumansLiverLiver Function TestsOxidative StressParenteral NutritionParenteral Nutrition SolutionsRisk FactorsAlanine Transaminasegamma-GlutamyltransferaseParenteral Nutrition SolutionsLipid emulsionLiver testsNon-critical patientParenteral nutritionRisk factor

Identifiers

PMID30474548
PMCPMC6260870
OpenAlexW2900936947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.